FDA Crackdown on GLP-1 Compounders Sends Shockwaves Through Industry, Hims Stock Plunges
FDA enforcement against GLP-1 compounding pharmacies triggers market chaos and raises questions about patient access to affordable medications.
-
-
FDA Approves Oral Wegovy, Marking a New Era for GLP-1 Weight Loss Treatment
FDA approves first oral GLP-1 for weight loss, offering daily pill alternative to weekly Wegovy injections.
